The present invention concerns a method for removal of immunosuppressive effects of envelope glycoproteins derived from human immunodeficiency virus, such as for vaccination purposes and for generation of neutralizing antibodies to HIV. The invention further concerns vaccines and antibodies obtainable by the method, as well as the use of such vaccines and antibodies.
